Sergey M. Deyev
Researcher Next ID · RN-042722
Researcher · Engineering
Moscow, New Zealand
- Works count
- 384
- Citation count
- 7,802
- H-index
- 45
- i10-index
- 180
Research interests
Publications
Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors
Advanced Drug Delivery Reviews · 2025 · 10.1016/j.addr.2025.115550
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
Nature Communications · 2024 · 10.1038/s41467-024-48838-5
Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors
Light Science & Applications · 2022 · 10.1038/s41377-022-00729-4
Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission
Pharmaceutics · 2022 · 10.3390/pharmaceutics14051013
Long-Term Fate of Magnetic Particles in Mice: A Comprehensive Study
ACS Nano · 2021 · 10.1021/acsnano.1c00687
Laser-synthesized TiN nanoparticles for biomedical applications: Evaluation of safety, biodistribution and pharmacokinetics
Materials Science and Engineering C · 2020 · 10.1016/j.msec.2020.111717
Fast processes of nanoparticle blood clearance: Comprehensive study
Journal of Controlled Release · 2020 · 10.1016/j.jconrel.2020.07.014
Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes
Nature Biomedical Engineering · 2020 · 10.1038/s41551-020-0581-2
In vivo blockade of mononuclear phagocyte system with solid nanoparticles: Efficiency and affecting factors
Journal of Controlled Release · 2020 · 10.1016/j.jconrel.2020.12.004
Plants with genetically encoded autoluminescence
Nature Biotechnology · 2020 · 10.1038/s41587-020-0500-9
Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth
Nanoscale · 2018 · 10.1039/c8nr07730d
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
Journal of Immunology Research · 2018 · 10.1155/2018/7394268
Radioactive ( 90 Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer
Proceedings of the National Academy of Sciences · 2018 · 10.1073/pnas.1809258115
Deep-penetrating photodynamic therapy with KillerRed mediated by upconversion nanoparticles
Acta Biomaterialia · 2017 · 10.1016/j.actbio.2017.01.004
Riboflavin photoactivation by upconversion nanoparticles for cancer treatment
Scientific Reports · 2016 · 10.1038/srep35103
Cytotoxicity and non-specific cellular uptake of bare and surface-modified upconversion nanoparticles in human skin cells
Nano Research · 2015 · 10.1007/s12274-014-0641-6
Biocomputing based on particle disassembly
Nature Nanotechnology · 2014 · 10.1038/nnano.2014.156
Genetically Encoded Immunophotosensitizer 4D5scFv-miniSOG is a Highly Selective Agent for Targeted Photokilling of Tumor Cells in Vitro
Theranostics · 2013 · 10.7150/thno.6715
Feasibility study of the optical imaging of a breast cancer lesion labeled with upconversion nanoparticle biocomplexes
Journal of Biomedical Optics · 2013 · 10.1117/1.jbo.18.7.076004
Protein-assisted self-assembly of multifunctional nanoparticles
Proceedings of the National Academy of Sciences · 2010 · 10.1073/pnas.1001142107
Modern Technologies for Creating Synthetic Antibodies for Clinical Application
Acta Naturae · 2009 · 10.32607/20758251-2009-1-1-32-50
Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein
Proceedings of the National Academy of Sciences · 2009 · 10.1073/pnas.0904140106
Barnase as a New Therapeutic Agent Triggering Apoptosis in Human Cancer Cells
PLoS ONE · 2008 · 10.1371/journal.pone.0002434
Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
BioEssays · 2008 · 10.1002/bies.20805
Design of multivalent complexes using the barnase·barstar module
Nature Biotechnology · 2003 · 10.1038/nbt916
Current projects
No projects listed.